The store will not work correctly when cookies are disabled.
ethyl 4-(4-fluorophenylselanyl)-6-methoxyquinoline-2-carboxylate
ID: ALA4639816
PubChem CID: 156015650
Max Phase: Preclinical
Molecular Formula: C19H16FNO3Se
Molecular Weight: 404.30
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)c1cc([Se]c2ccc(F)cc2)c2cc(OC)ccc2n1
Standard InChI: InChI=1S/C19H16FNO3Se/c1-3-24-19(22)17-11-18(25-14-7-4-12(20)5-8-14)15-10-13(23-2)6-9-16(15)21-17/h4-11H,3H2,1-2H3
Standard InChI Key: ZPBQJWBUGZVWOG-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
3.2591 -12.7283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2579 -13.5479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9660 -13.9568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9642 -12.3195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6728 -12.7247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6736 -13.5438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3821 -13.9508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0904 -13.5400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0856 -12.7179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3765 -12.3145 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3838 -14.7680 0.0000 Se 0 0 0 0 0 2 0 0 0 0 0 0
6.0924 -15.1751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0907 -15.9900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7984 -16.3970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5063 -15.9869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5020 -15.1655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7937 -14.7621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7909 -12.3050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5010 -12.7093 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.7859 -11.4878 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.2062 -12.2964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9164 -12.7006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5499 -13.9559 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8425 -13.5468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2154 -16.3931 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
7 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
9 18 1 0
18 19 1 0
18 20 2 0
19 21 1 0
21 22 1 0
2 23 1 0
23 24 1 0
15 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 404.30 | Molecular Weight (Monoisotopic): 405.0279 | AlogP: ┄ | #Rotatable Bonds: ┄ |
Polar Surface Area: ┄ | Molecular Species: ┄ | HBA: ┄ | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): ┄ | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: ┄ | CX LogD: ┄ |
Aromatic Rings: ┄ | Heavy Atoms: ┄ | QED Weighted: ┄ | Np Likeness Score: ┄ |
References
1. Costa CA, Lopes RM, Ferraz LS, Esteves GNN, Di Iorio JF, Souza AA, de Oliveira IM, Manarin F, Judice WAS, Stefani HA, Rodrigues T.. (2020) Cytotoxicity of 4-substituted quinoline derivatives: Anticancer and antileishmanial potential., 28 (11): [PMID:32336669] [10.1016/j.bmc.2020.115511] |